The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

Milo A. Puhan, Martin Frey, Stefan Büchi, Holger J. Schünemann

Research output: Contribution to journalArticle

Abstract

Background: Interpretation of the Hospital Anxiety and Depression Scale (HADS), commonly used to assess anxiety and depression in COPD patients, is unclear. Since its minimal important difference has never been established, our aim was to determine it using several approaches. Methods: 88 COPD patients with FEV1 ≤ 50% predicted completed the HADS and other patient-important outcome measures before and after an inpatient respiratory rehabilitation. For the anchor-based approach we determined the correlation between the HADS and the anchors that have an established minimal important difference (Chronic Respiratory Questionnaire [CRQ] and Feeling Thermometer). If correlations were ≥ 0.5 we performed linear regression analyses to predict the minimal important difference from the anchors. As distribution-based approach we used the Effect Size approach. Results: Based on CRQ emotional function and mastery domain as well as on total scores, the minimal important difference was 1.41 (95% CI 1.18-1.63) and 1.57 (1.37-1.76) for the HADS anxiety score and 1.68 (1.48-1.87) and 1.60 (1.38-1.82) for the HADS total score. Correlations of the HADS depression score and CRQ domain and Feeling Thermometer scores were <0.5. Based on the Effect Size approach the MID of the HADS anxiety and depression score was 1.32 and 1.40, respectively. Conclusion: The minimal important difference of the HADS is around 1.5 in COPD patients corresponding to a change from baseline of around 20%. It can be used for the planning and interpretation of trials.

Original languageEnglish (US)
Article number46
JournalHealth and Quality of Life Outcomes
Volume6
DOIs
StatePublished - Jul 2 2008
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Anxiety
Depression
Thermometers
Emotions
Inpatients
Linear Models
Rehabilitation
Regression Analysis
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. / Puhan, Milo A.; Frey, Martin; Büchi, Stefan; Schünemann, Holger J.

In: Health and Quality of Life Outcomes, Vol. 6, 46, 02.07.2008.

Research output: Contribution to journalArticle

@article{67f7debf2eed44edad0ea13d15db2649,
title = "The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease",
abstract = "Background: Interpretation of the Hospital Anxiety and Depression Scale (HADS), commonly used to assess anxiety and depression in COPD patients, is unclear. Since its minimal important difference has never been established, our aim was to determine it using several approaches. Methods: 88 COPD patients with FEV1 ≤ 50{\%} predicted completed the HADS and other patient-important outcome measures before and after an inpatient respiratory rehabilitation. For the anchor-based approach we determined the correlation between the HADS and the anchors that have an established minimal important difference (Chronic Respiratory Questionnaire [CRQ] and Feeling Thermometer). If correlations were ≥ 0.5 we performed linear regression analyses to predict the minimal important difference from the anchors. As distribution-based approach we used the Effect Size approach. Results: Based on CRQ emotional function and mastery domain as well as on total scores, the minimal important difference was 1.41 (95{\%} CI 1.18-1.63) and 1.57 (1.37-1.76) for the HADS anxiety score and 1.68 (1.48-1.87) and 1.60 (1.38-1.82) for the HADS total score. Correlations of the HADS depression score and CRQ domain and Feeling Thermometer scores were <0.5. Based on the Effect Size approach the MID of the HADS anxiety and depression score was 1.32 and 1.40, respectively. Conclusion: The minimal important difference of the HADS is around 1.5 in COPD patients corresponding to a change from baseline of around 20{\%}. It can be used for the planning and interpretation of trials.",
author = "Puhan, {Milo A.} and Martin Frey and Stefan B{\"u}chi and Sch{\"u}nemann, {Holger J.}",
year = "2008",
month = "7",
day = "2",
doi = "10.1186/1477-7525-6-46",
language = "English (US)",
volume = "6",
journal = "Health and Quality of Life Outcomes",
issn = "1477-7525",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

AU - Puhan, Milo A.

AU - Frey, Martin

AU - Büchi, Stefan

AU - Schünemann, Holger J.

PY - 2008/7/2

Y1 - 2008/7/2

N2 - Background: Interpretation of the Hospital Anxiety and Depression Scale (HADS), commonly used to assess anxiety and depression in COPD patients, is unclear. Since its minimal important difference has never been established, our aim was to determine it using several approaches. Methods: 88 COPD patients with FEV1 ≤ 50% predicted completed the HADS and other patient-important outcome measures before and after an inpatient respiratory rehabilitation. For the anchor-based approach we determined the correlation between the HADS and the anchors that have an established minimal important difference (Chronic Respiratory Questionnaire [CRQ] and Feeling Thermometer). If correlations were ≥ 0.5 we performed linear regression analyses to predict the minimal important difference from the anchors. As distribution-based approach we used the Effect Size approach. Results: Based on CRQ emotional function and mastery domain as well as on total scores, the minimal important difference was 1.41 (95% CI 1.18-1.63) and 1.57 (1.37-1.76) for the HADS anxiety score and 1.68 (1.48-1.87) and 1.60 (1.38-1.82) for the HADS total score. Correlations of the HADS depression score and CRQ domain and Feeling Thermometer scores were <0.5. Based on the Effect Size approach the MID of the HADS anxiety and depression score was 1.32 and 1.40, respectively. Conclusion: The minimal important difference of the HADS is around 1.5 in COPD patients corresponding to a change from baseline of around 20%. It can be used for the planning and interpretation of trials.

AB - Background: Interpretation of the Hospital Anxiety and Depression Scale (HADS), commonly used to assess anxiety and depression in COPD patients, is unclear. Since its minimal important difference has never been established, our aim was to determine it using several approaches. Methods: 88 COPD patients with FEV1 ≤ 50% predicted completed the HADS and other patient-important outcome measures before and after an inpatient respiratory rehabilitation. For the anchor-based approach we determined the correlation between the HADS and the anchors that have an established minimal important difference (Chronic Respiratory Questionnaire [CRQ] and Feeling Thermometer). If correlations were ≥ 0.5 we performed linear regression analyses to predict the minimal important difference from the anchors. As distribution-based approach we used the Effect Size approach. Results: Based on CRQ emotional function and mastery domain as well as on total scores, the minimal important difference was 1.41 (95% CI 1.18-1.63) and 1.57 (1.37-1.76) for the HADS anxiety score and 1.68 (1.48-1.87) and 1.60 (1.38-1.82) for the HADS total score. Correlations of the HADS depression score and CRQ domain and Feeling Thermometer scores were <0.5. Based on the Effect Size approach the MID of the HADS anxiety and depression score was 1.32 and 1.40, respectively. Conclusion: The minimal important difference of the HADS is around 1.5 in COPD patients corresponding to a change from baseline of around 20%. It can be used for the planning and interpretation of trials.

UR - http://www.scopus.com/inward/record.url?scp=47849097000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47849097000&partnerID=8YFLogxK

U2 - 10.1186/1477-7525-6-46

DO - 10.1186/1477-7525-6-46

M3 - Article

C2 - 18597689

AN - SCOPUS:47849097000

VL - 6

JO - Health and Quality of Life Outcomes

JF - Health and Quality of Life Outcomes

SN - 1477-7525

M1 - 46

ER -